N-Methyl-D-Aspartate (Nmda)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective Publisher Pubmed



Abhari AP^{1, 2} ; Etemadifar M³ ; Yazdanpanah N^{1, 4, 5} ; Rezaei N^{1, 5, 6} Show Affiliations
Source: Mini-Reviews in Medicinal Chemistry Published:2022

Abstract

N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors, highly important in regulating substantial physiologic processes in the brain and the nervous system, and disturbance in their function could contribute to different pathologies. Overstimulation and hyperactivity of NMDARs, termed glutamate toxicity, could promote cell death and apoptosis. Meanwhile, their blockade could lead to dysfunction of the brain and nervous system. A growing body of evidence has demonstrated the prominent role of NMDARs in demyelinating disorders and anti-NMDAR encephalitis. Herein, we provide an overview of NMDARs’ dysfunction in the physiopathology of demyelinating disorders such as multiple sclerosis and neuromyelitis optica spectrum disorders. © 2022 Bentham Science Publishers.